Nearly half of people diagnosed with advanced cancer over a recent 5-year period did not undergo next-generation sequencing, according to results of a retrospective cohort study.Rates improved over ...
"In our study, we showed that fine needle aspiration (FNA) biopsy material can be a good source for next-generation sequencing (NGS) for patients with metastatic prostate cancer. Based on these ...
NGS utilization increased over time but left substantial proportions untested across metastatic breast, prostate, pancreatic, ...
Foundation Medicine, Inc., a global precision medicine company, today announced an expansion to its collaboration with Bristol Myers Squibb (NYSE: BMY) to develop FoundationOne(R) CDx as a ...
Advances in next-generation sequencing (NGS) and synthetic DNA technologies are reshaping oncology research by enabling earlier cancer detection, more accurate biomarker discovery, and sensitive ...
VANCOUVER, BC, April 21, 2026 /CNW/ - Genetrack Biolabs, working in partnership with Canada's Michael Smith Genome Sciences Centre as part of a landmark research--industry collaboration, has announced ...
Real-World Plasma Thymidine Kinase Activity in High-Risk and Metastatic Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer Treated With Cyclin-Dependent Kinase ...
Inocras and the Broad Institute analyzed 8,000+ TCGA cancer genomes to uncover new drivers and create a harmonized dataset ...
Emerging opportunities in the cancer biomarkers market include the growth of personalized oncology, non-invasive diagnostics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results